Per-Lesion Assessment of Individual MRI Sequences and 68 Ga-DOTATATE PET in Neuroendocrine Liver Metastases

Investigative Radiology
|October 27, 2025
PubMed
Abstract

Insights

Magnetic resonance imaging (MRI) significantly outperforms gallium-68 (68Ga)-DOTATATE positron emission tomography (PET) in detecting neuroendocrine liver metastases (NELMs). Specific MRI sequences like diffusion-weighted imaging (DWI) and hepatobiliary phase (HBP) show high sensitivity, especially for small lesions.

Area of Science:

  • Radiology
  • Oncology
  • Nuclear Medicine

Background:

  • Neuroendocrine liver metastases (NELMs) pose diagnostic challenges.
  • Accurate detection is crucial for effective patient management and treatment planning.

Purpose of the Study:

  • To compare the diagnostic performance of MRI and 68Ga-DOTATATE PET for NELMs.
  • To evaluate the contribution of individual MRI sequences (DWI, DCE, HBP) in detecting NELMs.
  • To identify factors influencing lesion detection.

Main Methods:

  • Retrospective observational study of patients with confirmed neuroendocrine tumors.
  • Analysis of contrast-enhanced MRI and 68Ga-DOTATATE PET scans performed within 12 weeks.
  • Consensus assessment by three readers of MRI sequences, full MRI, and PET data.
  • Histopathology or follow-up imaging served as the reference standard.

Main Results:

  • MRI demonstrated superior sensitivity (93%) and accuracy (93%) compared to PET (59% and 63%, respectively).
  • Diffusion-weighted imaging (DWI) and hepatobiliary phase (HBP) imaging showed the highest sensitivity (89% and 92%).
  • MRI outperformed PET in detecting smaller metastases (<5 mm and 5-10 mm).

Conclusions:

  • MRI is more effective than 68Ga-DOTATATE PET for detecting NELMs.
  • DWI and HBP sequences are particularly valuable for identifying small NELMs.
  • MRI's superior performance aids in more comprehensive assessment of liver metastases.

Related Concept Videos

Imaging Studies II: Positron Emission Tomography and Scintigraphy01:25

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
493
Positron Emission Tomography01:29

Positron Emission Tomography

Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
6.9K
Radiological Investigation III: Pulmonary Angiogram and PET Scan01:13

Radiological Investigation III: Pulmonary Angiogram and PET Scan

Radiological investigations are paramount in the diagnosis and management of various pulmonary diseases. Two essential investigations are the Pulmonary Angiogram and the Positron Emission Tomography (PET) Scan.
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
402